This study evaluates the safety and tolerability of PH94B with repeated dosing over a period
of up to 12 months. Participating subjects will use PH94B up to 4 times a day when they
encounter anxiety-provoking situations in daily life. Safety and tolerability of PH94B ( 4
doses per day up to 12 months) will be assessed and summarized during monthly visits from
baseline (Visit 2) to end of treatment (Visit 14) in AEs, laboratory values, 12-lead ECGs,
physical examinations, and vital sign assessments following exposure to PH94B.
Claustrophobia, Phobia, Social, Social Anxiety Disorder (SAD), Social Phobia
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.